Join the club for FREE to access the whole archive and other member benefits.


Known as “the powerhouse of the cell”, mitochondria generate most of the cell’s supply of adenosine triphosphate (ATP) which transports chemical energy within cells for metabolism. They are membrane-bound organelle found in most eukaryotic cells.


Click on resource name for more details.


Cellvie develops cell-derived medicines, leveraging the therapeutic potential of mitochondria, the powerhouses of the cell

Mitrix Bio

California based start-up company

Stealth BioTherapeutics

Biopharmaceutical company focused on the discovery and commercialization of novel therapies..


Company focused on the research and development of mitochondria based therapeutics.

MitoRx Therapeutics

Pre-clinical stage rare disease biotech company aiming to develop treatments for degenerative diseases

Jay Parrish

Chairman and Chief Executive Officer at Pretzel Therapeutics

Pretzel Therapeutics

Biotechnology research company focussed on mitochondrial therapeutics

MDNA Life Sciences

Company that is pioneer in the science of mitochondrial DNA

Michael Sack

Senior Investigator at NHLBI Laboratory of Mitochondrial Biology and Metabolism

Mitochondria, Aging, and Health


Speakers are Douglas Wallace, Francesca Fieni, Hazel Szeto and Michael Zemel

More Mitochondria resources

Mitochondria Blog Posts

Antioxidants in ageing and health

Antioxidants in ageing and health

Reactive oxygen species (ROS) have a positive role in some processes, complicating research, but unlikely that antioxidants slow ageing

Mitochondria, Autophagy and Neurodegenerative diseases: A perspective

Mitochondria, Autophagy and Neurodegenerative diseases: A perspective

Review paper from University of Helsinki looks at the role of mitophagy in ageing

Recent News

cellvie closes $5.5 million of financing to develop its allogeneic mitochondria therapies

KIZOO Technology Ventures - 06-Feb-2023

Mitochondria dysfunction is linked to several ageing-related diseases, including neurodegeneration, so a big potential market


Mutated mtDNA acts as a molecular target for therapeutic treatments of age related diseases

University of Cologne - 16-Dec-2022

Targeting and eliminating mutated mtDNA by subjecting it to autophagy with rapamycin been successful


Mitochondria boosting therapy rejuvenates immune system of mice

Longevity Technology - 11-Oct-2022

If successful in humans it would improve the outcome of many age-related diseases


Longevity Technology interviews cellvie CEO, Alex Schueller, about therapeutic mitochondria

Longevity Technology - 14-Sep-2022

Initially targeting ischemia-reperfusion injury, TMT has potential to treat multiple age-related diseases


$72m funding launching Pretzel Therapeutics pioneering mitochondrial therapies

Biospace - 12-Sep-2022

Pretzel targets genome correction, genome expression modulation and mitochondrial quality control

More Mitochondria News